Ignite Creation Date:
2025-12-25 @ 5:02 AM
Ignite Modification Date:
2025-12-26 @ 4:03 AM
Study NCT ID:
NCT01548118
Status:
UNKNOWN
Last Update Posted:
2012-03-08
First Post:
2012-02-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females
Sponsor:
Shanghai Zerun Biotechnology Co.,Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2012-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2012-12
Completion Date Type:
ESTIMATED
First Submit Date:
2012-02-29
First Submit QC Date:
None
Study First Post Date:
2012-03-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-05
Last Update Post Date:
2012-03-08
Last Update Post Date Type:
ESTIMATED